Mount Sinai School of Medicine & Chemotherapy Foundation host leading cancer meeting on new ERA therapies
New York -- The Page and William Black Post-Graduate School of Medicine of Mount Sinai School of Medicine, the Division of Hematology and Medical Oncology of the Department of Medicine of Mount Sinai School of Medicine and the Chemotherapy Foundation will jointly sponsor "Innovative Cancer Therapy for Tomorrow," the 23rd annual symposium on the latest developments in cancer research and therapy from November 2-5 at the Marriott Marquis on Broadway between 45th and 46th Streets in Midtown Manhattan.
Daily schedules and registration information are available at http://www.mssm.edu/tcf/. The website also has presentations, abstracts and highlights from past symposia.
More than 1,000 medical oncologists from the United States and abroad will hear leading clinical investigators report on new developments in chemotherapy and biomodulation in management of cancer patients during the three-day conference. This year's symposium is dedicated to the memory of the founder of the Chemotherapy Foundation, Dr. Ezra Greenspan. Members of the media interested in attending, please contact email@example.com.
Source: Eurekalert & othersLast reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.